Report Detail

Request for Sample of this report

Pharma & Healthcare Global Anti-VEGF Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4586318
    • |
  • 09 April, 2024
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Anti-VEGF Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Anti-VEGF Injection industry chain, the market status of Age-related Macular Degeneration (AMD) (Ranibizumab, Bevacizumab), Diabetic Retinopathy (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-VEGF Injection.
Regionally, the report analyzes the Anti-VEGF Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-VEGF Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anti-VEGF Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-VEGF Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-VEGF Injection market.
Regional Analysis: The report involves examining the Anti-VEGF Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-VEGF Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anti-VEGF Injection:
Company Analysis: Report covers individual Anti-VEGF Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-VEGF Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration (AMD), Diabetic Retinopathy).
Technology Analysis: Report covers specific technologies relevant to Anti-VEGF Injection. It assesses the current state, advancements, and potential future developments in Anti-VEGF Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-VEGF Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anti-VEGF Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Others
Market segment by Application
Age-related Macular Degeneration (AMD)
Diabetic Retinopathy
Retinal Vein Occlusion (RVO)
Retinopathy of Prematurity (ROP)
Uveitis
Neovascular Glaucoma
Others
Major players covered
Roche
Bayer
Genentech
Novartis
Coherus BioSciences Inc.
Regeneron
Qilu Pharmaceutical Co.,Ltd.
Innovent Biologics
Anke Biotechnology
Shenzhen Kangzhe Pharmaceutical Co Ltd
Chengdu Kanghong Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-VEGF Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-VEGF Injection, with price, sales, revenue and global market share of Anti-VEGF Injection from 2019 to 2024.
Chapter 3, the Anti-VEGF Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-VEGF Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anti-VEGF Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-VEGF Injection.
Chapter 14 and 15, to describe Anti-VEGF Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Anti-VEGF Injection
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Anti-VEGF Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Ranibizumab
    • 1.3.3 Bevacizumab
    • 1.3.4 Aflibercept
    • 1.3.5 Brolucizumab
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Anti-VEGF Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Age-related Macular Degeneration (AMD)
    • 1.4.3 Diabetic Retinopathy
    • 1.4.4 Retinal Vein Occlusion (RVO)
    • 1.4.5 Retinopathy of Prematurity (ROP)
    • 1.4.6 Uveitis
    • 1.4.7 Neovascular Glaucoma
    • 1.4.8 Others
  • 1.5 Global Anti-VEGF Injection Market Size & Forecast
    • 1.5.1 Global Anti-VEGF Injection Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Anti-VEGF Injection Sales Quantity (2019-2030)
    • 1.5.3 Global Anti-VEGF Injection Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Anti-VEGF Injection Product and Services
    • 2.1.4 Roche Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Anti-VEGF Injection Product and Services
    • 2.2.4 Bayer Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bayer Recent Developments/Updates
  • 2.3 Genentech
    • 2.3.1 Genentech Details
    • 2.3.2 Genentech Major Business
    • 2.3.3 Genentech Anti-VEGF Injection Product and Services
    • 2.3.4 Genentech Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Genentech Recent Developments/Updates
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Anti-VEGF Injection Product and Services
    • 2.4.4 Novartis Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Novartis Recent Developments/Updates
  • 2.5 Coherus BioSciences Inc.
    • 2.5.1 Coherus BioSciences Inc. Details
    • 2.5.2 Coherus BioSciences Inc. Major Business
    • 2.5.3 Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
    • 2.5.4 Coherus BioSciences Inc. Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Coherus BioSciences Inc. Recent Developments/Updates
  • 2.6 Regeneron
    • 2.6.1 Regeneron Details
    • 2.6.2 Regeneron Major Business
    • 2.6.3 Regeneron Anti-VEGF Injection Product and Services
    • 2.6.4 Regeneron Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Regeneron Recent Developments/Updates
  • 2.7 Qilu Pharmaceutical Co.,Ltd.
    • 2.7.1 Qilu Pharmaceutical Co.,Ltd. Details
    • 2.7.2 Qilu Pharmaceutical Co.,Ltd. Major Business
    • 2.7.3 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
    • 2.7.4 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.8 Innovent Biologics
    • 2.8.1 Innovent Biologics Details
    • 2.8.2 Innovent Biologics Major Business
    • 2.8.3 Innovent Biologics Anti-VEGF Injection Product and Services
    • 2.8.4 Innovent Biologics Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Innovent Biologics Recent Developments/Updates
  • 2.9 Anke Biotechnology
    • 2.9.1 Anke Biotechnology Details
    • 2.9.2 Anke Biotechnology Major Business
    • 2.9.3 Anke Biotechnology Anti-VEGF Injection Product and Services
    • 2.9.4 Anke Biotechnology Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Anke Biotechnology Recent Developments/Updates
  • 2.10 Shenzhen Kangzhe Pharmaceutical Co Ltd
    • 2.10.1 Shenzhen Kangzhe Pharmaceutical Co Ltd Details
    • 2.10.2 Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
    • 2.10.3 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
    • 2.10.4 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
  • 2.11 Chengdu Kanghong Pharmaceutical Group
    • 2.11.1 Chengdu Kanghong Pharmaceutical Group Details
    • 2.11.2 Chengdu Kanghong Pharmaceutical Group Major Business
    • 2.11.3 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
    • 2.11.4 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Anti-VEGF Injection by Manufacturer

  • 3.1 Global Anti-VEGF Injection Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Anti-VEGF Injection Revenue by Manufacturer (2019-2024)
  • 3.3 Global Anti-VEGF Injection Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Anti-VEGF Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Anti-VEGF Injection Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Anti-VEGF Injection Manufacturer Market Share in 2023
  • 3.5 Anti-VEGF Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Anti-VEGF Injection Market: Region Footprint
    • 3.5.2 Anti-VEGF Injection Market: Company Product Type Footprint
    • 3.5.3 Anti-VEGF Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Anti-VEGF Injection Market Size by Region
    • 4.1.1 Global Anti-VEGF Injection Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Anti-VEGF Injection Consumption Value by Region (2019-2030)
    • 4.1.3 Global Anti-VEGF Injection Average Price by Region (2019-2030)
  • 4.2 North America Anti-VEGF Injection Consumption Value (2019-2030)
  • 4.3 Europe Anti-VEGF Injection Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Anti-VEGF Injection Consumption Value (2019-2030)
  • 4.5 South America Anti-VEGF Injection Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Anti-VEGF Injection Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Anti-VEGF Injection Sales Quantity by Type (2019-2030)
  • 5.2 Global Anti-VEGF Injection Consumption Value by Type (2019-2030)
  • 5.3 Global Anti-VEGF Injection Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Anti-VEGF Injection Sales Quantity by Application (2019-2030)
  • 6.2 Global Anti-VEGF Injection Consumption Value by Application (2019-2030)
  • 6.3 Global Anti-VEGF Injection Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Anti-VEGF Injection Sales Quantity by Type (2019-2030)
  • 7.2 North America Anti-VEGF Injection Sales Quantity by Application (2019-2030)
  • 7.3 North America Anti-VEGF Injection Market Size by Country
    • 7.3.1 North America Anti-VEGF Injection Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Anti-VEGF Injection Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Anti-VEGF Injection Sales Quantity by Type (2019-2030)
  • 8.2 Europe Anti-VEGF Injection Sales Quantity by Application (2019-2030)
  • 8.3 Europe Anti-VEGF Injection Market Size by Country
    • 8.3.1 Europe Anti-VEGF Injection Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Anti-VEGF Injection Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Anti-VEGF Injection Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Anti-VEGF Injection Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Anti-VEGF Injection Market Size by Region
    • 9.3.1 Asia-Pacific Anti-VEGF Injection Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Anti-VEGF Injection Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Anti-VEGF Injection Sales Quantity by Type (2019-2030)
  • 10.2 South America Anti-VEGF Injection Sales Quantity by Application (2019-2030)
  • 10.3 South America Anti-VEGF Injection Market Size by Country
    • 10.3.1 South America Anti-VEGF Injection Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Anti-VEGF Injection Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Anti-VEGF Injection Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Anti-VEGF Injection Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Anti-VEGF Injection Market Size by Country
    • 11.3.1 Middle East & Africa Anti-VEGF Injection Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Anti-VEGF Injection Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Anti-VEGF Injection Market Drivers
  • 12.2 Anti-VEGF Injection Market Restraints
  • 12.3 Anti-VEGF Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Anti-VEGF Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Anti-VEGF Injection
  • 13.3 Anti-VEGF Injection Production Process
  • 13.4 Anti-VEGF Injection Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Anti-VEGF Injection Typical Distributors
  • 14.3 Anti-VEGF Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Anti-VEGF Injection. Industry analysis & Market Report on Anti-VEGF Injection is a syndicated market report, published as Global Anti-VEGF Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Anti-VEGF Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,232.92
    		4,849.38
    		6,465.84
    		532,196.40
    		798,294.60
    		1,064,392.80
    		290,301.60
    		435,452.40
    		580,603.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo